As of 2:50pm ET
| -0.05 / -1.12%|
The 4 analysts offering 12-month price forecasts for NovaBay Pharmaceuticals Inc have a median target of 6.25, with a high estimate of 10.00 and a low estimate of 5.00. The median estimate represents a +42.05% increase from the last price of 4.40.
The current consensus among 4 polled investment analysts is to Buy stock in NovaBay Pharmaceuticals Inc. This rating has held steady since November, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.